Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose